These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1515155)

  • 21. Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.
    Bishop AL; Schild S; Patimalla B; Klein B; Camilli A
    Infect Immun; 2010 Oct; 78(10):4402-20. PubMed ID: 20679439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against infection with Vibrio cholerae by passive transfer of monoclonal antibodies to outer membrane antigens.
    Sciortino CV
    J Infect Dis; 1989 Aug; 160(2):248-52. PubMed ID: 2760481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The toxin-coregulated pilus is a colonization factor and protective antigen of Vibrio cholerae El Tor.
    Voss E; Manning PA; Attridge SR
    Microb Pathog; 1996 Mar; 20(3):141-53. PubMed ID: 8965675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody against the capsule of Vibrio cholerae O139 protects against experimental challenge.
    Sengupta DK; Boesman-Finkelstein M; Finkelstein RA
    Infect Immun; 1996 Jan; 64(1):343-5. PubMed ID: 8557361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The OmpU outer membrane protein, a potential adherence factor of Vibrio cholerae.
    Sperandio V; Girón JA; Silveira WD; Kaper JB
    Infect Immun; 1995 Nov; 63(11):4433-8. PubMed ID: 7591082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of intestinal immunity against V. cholerae: role of antibody to V. cholerae haemagglutinin in intestinal immunity.
    Chaicumpa W; Atthasisiha N
    Southeast Asian J Trop Med Public Health; 1977 Mar; 8(1):13-8. PubMed ID: 887992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae.
    Attridge SR; Rowley D
    J Infect Dis; 1983 Nov; 148(5):931-9. PubMed ID: 6195273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse model.
    Sharma DP; Thomas C; Hall RH; Levine MM; Attridge SR
    Vaccine; 1989 Oct; 7(5):451-6. PubMed ID: 2573216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
    Yang JS; An SJ; Jang MS; Song M; Han SH
    PLoS One; 2019; 14(3):e0213507. PubMed ID: 30845262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and characterisation of monoclonal antibodies to outer-membrane-protein antigens of Vibrio cholerae O1.
    Kabir S
    J Med Microbiol; 1991 Mar; 34(3):167-73. PubMed ID: 1901361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens.
    Richardson K; Kaper JB; Levine MM
    Infect Immun; 1989 Feb; 57(2):495-501. PubMed ID: 2912896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzyme-linked immunoassays for antibodies against Vibrio cholerae.
    Cooper GN; McNab CE; Jackson GD; Walker P
    Aust J Exp Biol Med Sci; 1983 Dec; 61 ( Pt 6)():713-25. PubMed ID: 6426450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of TcpF-A2-CTB chimera and evidence of additive protective efficacy of immunizing with TcpF and CTB in the suckling mouse model of cholera.
    Price GA; Holmes RK
    PLoS One; 2012; 7(8):e42434. PubMed ID: 22879984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae.
    Sears SD; Richardson K; Young C; Parker CD; Levine MM
    Infect Immun; 1984 May; 44(2):439-44. PubMed ID: 6715044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme-linked immunosorbent assay for determination of antibodies to Vibrio cholerae toxin-coregulated pili.
    Osek J; Jonson G; Svennerholm AM; Holmgren J
    APMIS; 1992 Nov; 100(11):1027-32. PubMed ID: 1361754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model.
    Sun DX; Mekalanos JJ; Taylor RK
    J Infect Dis; 1990 Jun; 161(6):1231-6. PubMed ID: 1971653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization of mice with vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission.
    Bishop AL; Tarique AA; Patimalla B; Calderwood SB; Qadri F; Camilli A
    J Infect Dis; 2012 Feb; 205(3):412-21. PubMed ID: 22147790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vibrio cholerae expresses cell surface antigens during intestinal infection which are not expressed during in vitro culture.
    Jonson G; Svennerholm AM; Holmgren J
    Infect Immun; 1989 Jun; 57(6):1809-15. PubMed ID: 2722240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.